|
**Overview**: Protein Electrophoresis 24-Hour Urine Panel**Introduction**: The Protein Electrophoresis 24-Hour Urine Panel is a diagnostic tool designed to assess urinary protein fractions using timed urine collection. In India, proteinuria in multiple myeloma (~10,000-15,000 cases/year) often shows Bence-Jones proteins (light chains), essential for diagnosis and monitoring. High morbidity from under-testing in rural/low-SES elderly with bone pain, anemia, or renal failure, limited electrophoresis labs, delayed chemotherapy leading to progression or renal damage. Per hematology practices aligned with ICMR and Indian Society of Haematology & Blood Transfusion guidelines, the test employs electrophoresis for protein electrophoresis and total protein over 1-2 days with high accuracy, valuable for detecting monoclonal light chains. This diagnostic falls under protein screening and targets patients with suspected myeloma or unexplained proteinuria, addressing accurate detection to guide bone marrow biopsy or therapy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise protein fraction analysis and reducing myeloma complications. Its 24-hour urine-based approach ensures reliable quantitative profiling.**Other Names**: Protein Elec U Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/clinical pathology, compliant with 2025 standards.**Historical Milestone**: Urine protein electrophoresis standard in myeloma; in India, routine in hematology.**Purpose**: The test assesses 2 parameters including protein electrophoresis to guide protein screening, detect monoclonal bands, inform myeloma workup.**Test Parameters**: 1. Protein Electrophoresis, 2. Total Protein.**Pretest Condition**: No fasting required; patients should collect complete 24-hour urine.**Specimen**: 10 mL aliquot from 24-hour urine in 1 sterile container, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 24 hours with proper handling to preserve protein integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on bone pain, anemia.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected myeloma including renal failure, benefits of assessment, and minimal discomfort from collection.**Procedural Considerations**: The test involves sample processing using electrophoresis by trained personnel to ensure sterile technique and interpret patterns within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Incomplete collection, delays beyond stability periods, improper storage conditions can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Monoclonal light chains (Bence-Jones) indicate myeloma, necessitating specialist input.**Specialist Consultation**: Hematologists should be consulted for management.**Additional Supporting Tests**: Serum electrophoresis, immunofixation for confirmation.**Test Limitations**: Collection inconvenience; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Myeloma Studies India 2023. |
